title: Emerging therapies for soft-tissue sarcomas.
abstract: Sarcomas are heterogeneous group of tumors that arise from tissues of mesenchymal origin. Current options for patients with advanced disease are limited, and only 2 drugs have been approved for these diseases over the last decade. Although several drugs are currently under development for soft-tissue sarcoma as a whole, improved understanding of sarcoma biology has led to the emergence of subtype-specific targeted therapy. This article reviews recent clinical data on emerging therapies for soft-tissue sarcoma.
authors.affiliation: Department of Medical Oncology, Léon Bérard Cancer Center, 28 rue Laennec, Lyon 69008, France.
authors.forename: Alice
authors.initials: A
authors.lastname: Levard
authors.forename: Louis
authors.initials: L
authors.lastname: Tassy
authors.forename: Philippe A
authors.initials: PA
authors.lastname: Cassier
mesh_terms: D006801:Humans; D012509:Sarcoma / Q000188:drug therapy*
keywords: Cancer; Drug development; Sarcoma; Therapy; Tumor